Lisata Therapeutics Files 8-K on Shareholder Vote Matters
Ticker: LSTA · Form: 8-K · Filed: Jun 10, 2025 · CIK: 320017
| Field | Detail |
|---|---|
| Company | Lisata Therapeutics, Inc. (LSTA) |
| Form Type | 8-K |
| Filed Date | Jun 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, filing-update
Related Tickers: LISATA
TL;DR
Lisata Therapeutics (LISATA) is having a shareholder vote on corporate matters.
AI Summary
Lisata Therapeutics, Inc. filed an 8-K on June 10, 2025, to report on the submission of matters to a vote of security holders. The company, formerly known as Caladrius Biosciences, Inc., is incorporated in Delaware and operates in the pharmaceutical preparations sector.
Why It Matters
This filing indicates that Lisata Therapeutics is seeking shareholder approval for certain corporate actions, which could impact the company's future strategic direction and governance.
Risk Assessment
Risk Level: low — The filing is procedural, reporting on a shareholder vote, and does not disclose new financial or operational risks.
Key Players & Entities
- LISATA THERAPEUTICS, INC. (company) — Registrant
- June 10, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 2834 (sic_code) — Standard Industrial Classification for Pharmaceutical Preparations
- CALADRIUS BIOSCIENCES, INC. (company) — Former Company Name
- 110 Allen Road, Second Floor, Basking Ridge, NJ 07920 (address) — Principal Executive Offices
- 908-229-2590 (phone_number) — Business Phone
FAQ
What specific matters are being submitted for a vote by Lisata Therapeutics' security holders?
The filing states that the report concerns 'Submission of Matters to a Vote of Security Holders,' but the specific details of these matters are not provided in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on June 10, 2025, which is also the date of the report.
What was Lisata Therapeutics, Inc. formerly known as?
Lisata Therapeutics, Inc. was formerly known as Caladrius Biosciences, Inc.
In which state is Lisata Therapeutics, Inc. incorporated?
Lisata Therapeutics, Inc. is incorporated in Delaware.
What is the principal executive office address for Lisata Therapeutics, Inc.?
The principal executive office address for Lisata Therapeutics, Inc. is 110 Allen Road, Second Floor, Basking Ridge, NJ 07920.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 10, 2025 regarding LISATA THERAPEUTICS, INC. (LSTA).